vs
UiPath, Inc.（PATH）与SelectQuote, Inc.（SLQT）财务数据对比。点击上方公司名可切换其他公司
SelectQuote, Inc.的季度营收约是UiPath, Inc.的1.3倍（$537.1M vs $411.1M），UiPath, Inc.净利率更高（48.4% vs 12.9%，领先35.5%），UiPath, Inc.同比增速更快（15.9% vs 11.6%），UiPath, Inc.自由现金流更多（$25.1M vs $-1.0M），过去两年SelectQuote, Inc.的营收复合增速更高（19.5% vs 0.7%）
UiPath是一家全球化软件企业，专注于开发人工智能、智能自动化及流程编排类软件，其产品支持用户搭建与调度AI代理，实现复杂业务流程、工作流的自动化运行，助力各行业客户提升运营效率、降低人力成本。
SelectQuote是面向消费者的直售平台，主营保险产品与医疗服务业务，通过对接消费者与保险机构获取佣金，覆盖长者健康险、人寿险、车险、家财险等品类，医疗服务板块以认证药房SelectRx为核心业务，公司于2020年5月上市。
PATH vs SLQT — 直观对比
营收规模更大
SLQT
是对方的1.3倍
$411.1M
营收增速更快
PATH
高出4.3%
11.6%
净利率更高
PATH
高出35.5%
12.9%
自由现金流更多
PATH
多$26.1M
$-1.0M
两年增速更快
SLQT
近两年复合增速
0.7%
损益表 — Q3 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $411.1M | $537.1M |
| 净利润 | $198.8M | $69.3M |
| 毛利率 | 83.3% | 61.8% |
| 营业利润率 | 3.2% | 14.0% |
| 净利率 | 48.4% | 12.9% |
| 营收同比 | 15.9% | 11.6% |
| 净利润同比 | 1966.2% | 30.2% |
| 每股收益（稀释后） | $0.37 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PATHSLQT
| Q4 25 | $411.1M | $537.1M | ||
| Q3 25 | $361.7M | $328.8M | ||
| Q2 25 | $356.6M | $345.1M | ||
| Q1 25 | $423.6M | $408.2M | ||
| Q4 24 | $354.7M | $481.1M | ||
| Q3 24 | $316.3M | $292.3M | ||
| Q2 24 | $335.1M | $307.2M | ||
| Q1 24 | $405.3M | $376.4M |
净利润PATHSLQT
| Q4 25 | $198.8M | $69.3M | ||
| Q3 25 | $1.6M | $-30.5M | ||
| Q2 25 | $-22.6M | $12.9M | ||
| Q1 25 | $51.8M | $26.0M | ||
| Q4 24 | $-10.7M | $53.2M | ||
| Q3 24 | $-86.1M | $-44.5M | ||
| Q2 24 | $-28.7M | $-31.0M | ||
| Q1 24 | $33.9M | $8.6M |
毛利率PATHSLQT
| Q4 25 | 83.3% | 61.8% | ||
| Q3 25 | 82.2% | 41.4% | ||
| Q2 25 | 82.1% | 47.2% | ||
| Q1 25 | 84.8% | 60.2% | ||
| Q4 24 | 82.0% | 67.5% | ||
| Q3 24 | 80.0% | 55.7% | ||
| Q2 24 | 83.5% | 60.7% | ||
| Q1 24 | 86.8% | 71.8% |
营业利润率PATHSLQT
| Q4 25 | 3.2% | 14.0% | ||
| Q3 25 | -5.6% | -12.4% | ||
| Q2 25 | -4.6% | -3.6% | ||
| Q1 25 | 7.9% | 5.4% | ||
| Q4 24 | -12.2% | 14.7% | ||
| Q3 24 | -32.7% | -4.1% | ||
| Q2 24 | -14.8% | -0.5% | ||
| Q1 24 | 3.7% | 8.8% |
净利率PATHSLQT
| Q4 25 | 48.4% | 12.9% | ||
| Q3 25 | 0.4% | -9.3% | ||
| Q2 25 | -6.3% | 3.7% | ||
| Q1 25 | 12.2% | 6.4% | ||
| Q4 24 | -3.0% | 11.1% | ||
| Q3 24 | -27.2% | -15.2% | ||
| Q2 24 | -8.6% | -10.1% | ||
| Q1 24 | 8.4% | 2.3% |
每股收益（稀释后）PATHSLQT
| Q4 25 | $0.37 | $0.26 | ||
| Q3 25 | $0.00 | $-0.26 | ||
| Q2 25 | $-0.04 | $-0.06 | ||
| Q1 25 | $0.09 | $0.03 | ||
| Q4 24 | $-0.02 | $0.30 | ||
| Q3 24 | $-0.15 | $-0.26 | ||
| Q2 24 | $-0.05 | $-0.17 | ||
| Q1 24 | $0.07 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $18.3M |
| 总债务越低越好 | — | $405.8M |
| 股东权益账面价值 | $1.9B | $359.7M |
| 总资产 | $2.9B | $1.4B |
| 负债/权益比越低杠杆越低 | — | 1.13× |
8季度趋势，按日历期对齐
现金及短期投资PATHSLQT
| Q4 25 | $1.4B | $18.3M | ||
| Q3 25 | $1.4B | $10.7M | ||
| Q2 25 | $1.6B | $32.4M | ||
| Q1 25 | $1.6B | $80.1M | ||
| Q4 24 | $1.6B | $7.3M | ||
| Q3 24 | $1.7B | $10.4M | ||
| Q2 24 | $1.9B | $42.7M | ||
| Q1 24 | $1.9B | $37.8M |
总债务PATHSLQT
| Q4 25 | — | $405.8M | ||
| Q3 25 | — | $393.1M | ||
| Q2 25 | — | $385.1M | ||
| Q1 25 | — | $391.5M | ||
| Q4 24 | — | $711.9M | ||
| Q3 24 | — | $680.4M | ||
| Q2 24 | — | $683.3M | ||
| Q1 24 | — | $686.0M |
股东权益PATHSLQT
| Q4 25 | $1.9B | $359.7M | ||
| Q3 25 | $1.7B | $305.1M | ||
| Q2 25 | $1.7B | $351.1M | ||
| Q1 25 | $1.8B | $350.2M | ||
| Q4 24 | $1.7B | $326.0M | ||
| Q3 24 | $1.8B | $269.4M | ||
| Q2 24 | $2.0B | $316.8M | ||
| Q1 24 | $2.0B | $346.8M |
总资产PATHSLQT
| Q4 25 | $2.9B | $1.4B | ||
| Q3 25 | $2.6B | $1.2B | ||
| Q2 25 | $2.6B | $1.2B | ||
| Q1 25 | $2.9B | $1.3B | ||
| Q4 24 | $2.7B | $1.3B | ||
| Q3 24 | $2.7B | $1.1B | ||
| Q2 24 | $2.8B | $1.2B | ||
| Q1 24 | $3.0B | $1.2B |
负债/权益比PATHSLQT
| Q4 25 | — | 1.13× | ||
| Q3 25 | — | 1.29× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | — | 1.12× | ||
| Q4 24 | — | 2.18× | ||
| Q3 24 | — | 2.53× | ||
| Q2 24 | — | 2.16× | ||
| Q1 24 | — | 1.98× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.3M | $52.0K |
| 自由现金流经营现金流 - 资本支出 | $25.1M | $-1.0M |
| 自由现金流率自由现金流/营收 | 6.1% | -0.2% |
| 资本支出强度资本支出/营收 | 0.8% | 0.2% |
| 现金转化率经营现金流/净利润 | 0.14× | 0.00× |
| 过去12个月自由现金流最近4个季度 | — | $8.5M |
8季度趋势，按日历期对齐
经营现金流PATHSLQT
| Q4 25 | $28.3M | $52.0K | ||
| Q3 25 | $41.6M | $-21.6M | ||
| Q2 25 | $119.0M | $-37.5M | ||
| Q1 25 | $146.1M | $71.1M | ||
| Q4 24 | $28.1M | $-28.7M | ||
| Q3 24 | $46.4M | $-16.6M | ||
| Q2 24 | $100.0M | $20.0M | ||
| Q1 24 | $145.6M | $44.5M |
自由现金流PATHSLQT
| Q4 25 | $25.1M | $-1.0M | ||
| Q3 25 | — | $-22.7M | ||
| Q2 25 | $106.2M | $-38.0M | ||
| Q1 25 | $138.7M | $70.2M | ||
| Q4 24 | $23.2M | $-29.0M | ||
| Q3 24 | $45.0M | $-17.1M | ||
| Q2 24 | $98.8M | $19.7M | ||
| Q1 24 | $141.8M | $43.4M |
自由现金流率PATHSLQT
| Q4 25 | 6.1% | -0.2% | ||
| Q3 25 | — | -6.9% | ||
| Q2 25 | 29.8% | -11.0% | ||
| Q1 25 | 32.7% | 17.2% | ||
| Q4 24 | 6.5% | -6.0% | ||
| Q3 24 | 14.2% | -5.8% | ||
| Q2 24 | 29.5% | 6.4% | ||
| Q1 24 | 35.0% | 11.5% |
资本支出强度PATHSLQT
| Q4 25 | 0.8% | 0.2% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 3.6% | 0.1% | ||
| Q1 25 | 1.7% | 0.2% | ||
| Q4 24 | 1.4% | 0.1% | ||
| Q3 24 | 0.4% | 0.2% | ||
| Q2 24 | 0.4% | 0.1% | ||
| Q1 24 | 0.9% | 0.3% |
现金转化率PATHSLQT
| Q4 25 | 0.14× | 0.00× | ||
| Q3 25 | 26.25× | — | ||
| Q2 25 | — | -2.91× | ||
| Q1 25 | 2.82× | 2.73× | ||
| Q4 24 | — | -0.54× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 4.29× | 5.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PATH
| Subscription Services | $247.6M | 60% |
| License | $150.0M | 36% |
| Professional Services And Other | $13.5M | 3% |
SLQT
| Healthcare Services Segment | $230.7M | 43% |
| Pharmacy | $227.2M | 42% |
| Other | $30.4M | 6% |
| Final Expense | $20.4M | 4% |
| Term | $18.5M | 3% |
| Other Senior | $6.3M | 1% |
| All Other Revenue | $3.9M | 1% |
